Asia-Pacific Nuclear Imaging Market Size and Share

Asia-Pacific Nuclear Imaging Market (2025 - 2030)
View Global Report

Asia-Pacific Nuclear Imaging Market Analysis by Mordor Intelligence

The Asia-Pacific Nuclear Imaging Market size is estimated at USD 1.58 billion in 2025, and is expected to reach USD 1.95 billion by 2030, at a CAGR of 4.23% during the forecast period (2025-2030).

The factors that are propelling the growth of the market include technological advancements, increasing diagnostic applications in various diseases, such as cancer and cardiovascular diseases, and the growing burden of these chronic diseases.

Over recent years, scientists, researchers, and technologists have been able to bring systems in clinical practice, in which two or even more than two standalone diagnostic imaging modalities are combined. Some of those multimodality imaging systems include PET/CT, SPECT/CT, PET/MRI, and PET/SPECT/CT. The shift from standalone to hybrid modalities have improved the applications of these devices in recent times.

Moreover, the rise in the prevalence of cancer and cardiac ailments is one of the primary drivers for the market. Nuclear medicine is hugely capable of treating cancer and cardiac diseases. Asia Pacific region has the highest populous countries like China and India, which in turn contribute to a large aging population. There is also a higher disease incidence in this region increases the demand for advanced technologies like nuclear imaging. There is a large investment on the healthcare setup and medical research making these facilities accessible. The per capita income is increasing in these countries making such technologies more affordable.

Competitive Landscape

The Asia Pacific nuclear imaging market is highly competitive and consists of a few major players. In terms of market share, few of the major players currently dominate the market. Companies, like Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers, among others, hold a substantial share in the market.

Asia-Pacific Nuclear Imaging Industry Leaders

  1. Canon Medical Systems Corporation

  2. Siemens Healthineers

  3. Koninklijke Philips NV

  4. GE Healthcare

  5. Neusoft Medical Systems Co., Ltd.

  6. *Disclaimer: Major Players sorted in no particular order
Asia Pacific Nuclear Imaging Market.png
Need More Details on Market Players and Competitors?
Download PDF

Table of Contents for Asia-Pacific Nuclear Imaging Industry Report

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Prevalence of Cancer and Cardiac Disorders
    • 4.2.2 Increase in Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Limited Reimbursement and Stringent Regulatory Procedures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Equipment
    • 5.1.2 Radioisotope
    • 5.1.2.1 SPECT Radioisotopes
    • 5.1.2.1.1 Technetium-99m (TC-99m)
    • 5.1.2.1.2 Thallium-201 (TI-201)
    • 5.1.2.1.3 Gallium(Ga-67)
    • 5.1.2.1.4 Iodine (I-123)
    • 5.1.2.1.5 Other SPECT Radioisotopes
    • 5.1.2.2 PET Radioisotopes
    • 5.1.2.2.1 Fluorine-18 (F-18)
    • 5.1.2.2.2 Rubidium-82 (RB-82)
    • 5.1.2.2.3 Other PET Radioisotopes
  • 5.2 By Application
    • 5.2.1 SPECT Applications
    • 5.2.1.1 Cardiology
    • 5.2.1.2 Neurology
    • 5.2.1.3 Thyroid
    • 5.2.1.4 Other SPECT Applications
    • 5.2.2 PET Applications
    • 5.2.2.1 Oncology
    • 5.2.2.2 Cardiology
    • 5.2.2.3 Neurology
    • 5.2.2.4 Other PET Applications
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
    • 5.3.1.1 China
    • 5.3.1.2 Japan
    • 5.3.1.3 India
    • 5.3.1.4 Australia
    • 5.3.1.5 South Korea
    • 5.3.1.6 Rest of Asia-Pacific

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Canon Medical Systems Corporation
    • 6.1.2 Siemens Healthineers
    • 6.1.3 Koninklijke Philips NV
    • 6.1.4 GE Healthcare
    • 6.1.5 Neusoft Medical Systems Co., Ltd.
    • 6.1.6 MiE GmbH
    • 6.1.7 Urenco
    • 6.1.8 Taiyo Nippon Sanso
    • 6.1.9 Bracco Imaging SpA
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Asia-Pacific Nuclear Imaging Market Report Scope

Nuclear medicine imaging procedures are non-invasive, with the exception of intravenous injections, and are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. These radiopharmaceuticals are used in diagnosis and therapeutics. They are small substances that contain a radioactive substance that is used in the treatment of cancer, cardiac and neurological disorders.

By Product Type
Equipment
Radioisotope SPECT Radioisotopes Technetium-99m (TC-99m)
Thallium-201 (TI-201)
Gallium(Ga-67)
Iodine (I-123)
Other SPECT Radioisotopes
PET Radioisotopes Fluorine-18 (F-18)
Rubidium-82 (RB-82)
Other PET Radioisotopes
By Application
SPECT Applications Cardiology
Neurology
Thyroid
Other SPECT Applications
PET Applications Oncology
Cardiology
Neurology
Other PET Applications
Geography
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
By Product Type Equipment
Radioisotope SPECT Radioisotopes Technetium-99m (TC-99m)
Thallium-201 (TI-201)
Gallium(Ga-67)
Iodine (I-123)
Other SPECT Radioisotopes
PET Radioisotopes Fluorine-18 (F-18)
Rubidium-82 (RB-82)
Other PET Radioisotopes
By Application SPECT Applications Cardiology
Neurology
Thyroid
Other SPECT Applications
PET Applications Oncology
Cardiology
Neurology
Other PET Applications
Geography Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

How big is the Asia Pacific Nuclear Imaging Market?

The Asia Pacific Nuclear Imaging Market size is expected to reach USD 1.58 billion in 2025 and grow at a CAGR of 4.23% to reach USD 1.95 billion by 2030.

What is the current Asia Pacific Nuclear Imaging Market size?

In 2025, the Asia Pacific Nuclear Imaging Market size is expected to reach USD 1.58 billion.

Who are the key players in Asia Pacific Nuclear Imaging Market?

Canon Medical Systems Corporation, Siemens Healthineers, Koninklijke Philips NV, GE Healthcare and Neusoft Medical Systems Co., Ltd. are the major companies operating in the Asia Pacific Nuclear Imaging Market.

What years does this Asia Pacific Nuclear Imaging Market cover, and what was the market size in 2024?

In 2024, the Asia Pacific Nuclear Imaging Market size was estimated at USD 1.51 billion. The report covers the Asia Pacific Nuclear Imaging Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Asia Pacific Nuclear Imaging Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Page last updated on:

Asia-Pacific Nuclear Imaging Market Report Snapshots